Asia-Pacific is set to exhibit the fastest-growing market for UTI during the review period. The regional market growth is attributed to the increasing awareness of urinary tract diseases, increasing educational activity, and the availability of different diagnostic and therapeutic methods to manage the infection. The regional market is segmented into France, Germany, Italy, Spain, and the UK. Additionally, the global market growth is driven by the increasing technological advancements in diagnostics and therapeutic products coupled with the rising prevalence of urinary tract diseases and other kidney problems.Įurope is expected to register the second-largest market of the Global Urinary Tract Infection. The market in the Americas is categorized into North America and Latin America. The regional market growth is driven by the presence of key manufacturers, the increasing prevalence of urinary tract infections, and the increasing aging woman population in the region. The Americas is likely to dominate the global market owing to the largest market share of 33.6% of the global market in 2019. Geographically, the global UTI market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. By end-user category, the global urinary tract infections market has been classified into hospitals, clinics, self-administered, and others.
In terms of the pathogen, the market has been categorized into Escherichia coli, Staphylococcus saprophyticus, Klebsiella pneumoniae, Proteus mirabilis, and Enterococcus faecalis. The Global Urinary Tract Infections Market, based on application, has been divided into urethritis, cystitis, and pyelonephritis. The β-lactam is further divided into amoxicillin-clavulanate, cefdinir, cefaclor, and cefpodoxime-proxetil. The cephalosporin is again classified into avycaz, cedax, cefdinir, and cefditoren. The quinolones segment is further sub-divided into ciprofloxacin, enoxacin, norfloxacin, ofloxacin, pefloxacin, and fleroxacin. In terms of drug class, the market has been classified into quinolones, β-lactam and cephalosporins, aminoglycosides, penicillin, and azoles. Global Urinary Tract Infections Market has been segmented into Drug Class, Application, Pathogen, End User. However, complex regulatory requirements are anticipated to restrain the growth of the global urinary tract infection market during the review period. An increasing prevalence of diabetic population is expected to boost the global UTI patients worldwide. Urological health issues are more common in diabetic patients. As per the World Health Organization, 1 million hospitalizations of women occur each year due to UTIs, which affect almost half the female population around the world. Global Urinary Tract Infections Market is expected to register the highest market growth owing to the largest market value of USD 9,490.88 Million in 2019. The major causes of UTI infection are unsafe sex, lack of hygiene, and diabetes. The infection in urinary system parts such as kidneys, ureters, bladder, and urethra are referred to as urinary tract infection. Global Urinary Tract Infections Market is anticipated to exhibit a CAGR of 3.62% during the review period of 2020 to 2027. Urinary Tract Infection Market Research Reportâ≏orecast till 2027 Get a Sample Copy of the Urinary Tract Infection Market Report 2021ĭescription About Urinary Tract Infection Market: TOP Manufactures in Urinary Tract Infection Market Report are:. It analyzes competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To project the consumption of Urinary Tract Infection submarkets, with respect to key regions (along with their respective key countries). Urinary Tract Infection Market share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Moreover, the report offers a detailed information about the position, scope of growth, and opportunities of new entrants or players in the market. The Urinary Tract Infection Market report provides a clear picture regarding RandD investment from key players and adoption of innovative technologies to widen their consumer base and expand the existing competitive position.
0 kommentar(er)
